Mahalia S. Desruisseaux

Infectious Disease

20 York St
New Haven, CT 06510

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

COVID-19 Convalescent Plasma Therapy: Long-term Implications.

COVID-19 Convalescent Plasma Therapy: Long-term Implications.

Journal: Open forum infectious diseases

Published: October 27, 2023

Integrated Care Models: HIV and Substance Use.

Integrated Care Models: HIV and Substance Use.

Journal: Current HIV/AIDS reports

Published: August 30, 2023

Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.

Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 05, 2022

Effects of anti-tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria.

Effects of anti-tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria.

Journal: Journal of neurochemistry

Published: August 08, 2022

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.

Journal: JAMA internal medicine

Published: December 13, 2021

Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19.

Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19.

Journal: PloS one

Published: April 26, 2021

Inclusion, Diversity, Access, and Equity (IDA&E) Roadmap: Infectious Diseases Society of America's Commitment to the Future.

Inclusion, Diversity, Access, and Equity (IDA&E) Roadmap: Infectious Diseases Society of America's Commitment to the Future.

Journal: The Journal of infectious diseases

Published: September 14, 2020

Endothelins in inflammatory neurological diseases.

Endothelins in inflammatory neurological diseases.

Journal: Pharmacology & therapeutics

Published: October 07, 2018

Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.

Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.

Journal: Infection and immunity

Published: September 29, 2017

Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.

Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.

Journal: The American journal of pathology

Published: September 20, 2015

Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria.

Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria.

Journal: PLoS pathogens

Published: July 14, 2015

Endothelin-1 and its role in the pathogenesis of infectious diseases.

Endothelin-1 and its role in the pathogenesis of infectious diseases.

Journal: Life sciences

Published: January 14, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026